UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.333
EU - Europa 6.334
AS - Asia 5.554
SA - Sud America 995
OC - Oceania 200
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 16
Totale 30.488
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.115
SG - Singapore 2.033
CN - Cina 1.661
UA - Ucraina 1.412
IT - Italia 1.400
BR - Brasile 909
RU - Federazione Russa 909
DE - Germania 768
IE - Irlanda 632
VN - Vietnam 480
KR - Corea 412
TR - Turchia 389
SE - Svezia 330
FI - Finlandia 311
HK - Hong Kong 299
GB - Regno Unito 175
CA - Canada 148
EE - Estonia 146
NZ - Nuova Zelanda 102
IN - India 101
AU - Australia 98
NL - Olanda 48
FR - Francia 46
AT - Austria 43
MX - Messico 41
AR - Argentina 29
CZ - Repubblica Ceca 28
BD - Bangladesh 27
IQ - Iraq 24
JP - Giappone 22
PL - Polonia 18
UZ - Uzbekistan 17
EU - Europa 16
EC - Ecuador 14
MA - Marocco 14
PK - Pakistan 14
ES - Italia 13
ZA - Sudafrica 12
IL - Israele 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 8
BE - Belgio 8
CO - Colombia 8
KE - Kenya 8
CL - Cile 7
EG - Egitto 7
ID - Indonesia 7
JM - Giamaica 7
NP - Nepal 7
PY - Paraguay 7
SA - Arabia Saudita 6
CR - Costa Rica 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
GR - Grecia 5
LT - Lituania 5
BO - Bolivia 4
CH - Svizzera 4
IR - Iran 4
JO - Giordania 4
LU - Lussemburgo 4
PH - Filippine 4
RO - Romania 4
TN - Tunisia 4
TW - Taiwan 4
AZ - Azerbaigian 3
DZ - Algeria 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
ET - Etiopia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
RS - Serbia 2
SV - El Salvador 2
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
Totale 30.477
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.156
Wilmington 2.250
Jacksonville 1.729
Princeton 1.634
Chandler 1.535
Singapore 748
Houston 729
Woodbridge 616
Dublin 593
Dong Ket 459
Ashburn 432
Nanjing 399
Andover 368
Izmir 364
Beijing 324
Moscow 312
Boardman 297
Hong Kong 293
Pellezzano 264
Düsseldorf 216
Mestre 203
Naples 149
Tallinn 146
Norwalk 143
Shenyang 134
Fairfield 131
Salerno 122
Hebei 121
Munich 121
Changsha 110
Nanchang 108
Dearborn 107
Los Angeles 89
Jiaxing 85
São Paulo 73
Redwood City 60
Rome 59
Dallas 57
The Dalles 56
Tianjin 56
San Diego 49
Nuremberg 48
Pune 46
Auckland 43
Columbus 42
Sydney 42
Milan 35
Turku 35
West Jordan 35
New York 34
Belo Horizonte 31
Cambridge 31
Washington 31
San Francisco 30
Jinan 29
Rio de Janeiro 29
Seattle 29
Casoria 28
Amsterdam 27
Ottawa 27
Council Bluffs 21
Fort Worth 21
Guangzhou 21
Montreal 21
Brasília 20
Lappeenranta 20
Stockholm 20
Springfield 19
Venezia 18
Brooklyn 17
Shanghai 17
Melbourne 16
Atlanta 15
Brno 15
Santa Clara 15
Tashkent 15
Vienna 15
Campinas 14
Curitiba 14
Lecce 14
Hangzhou 13
Bologna 12
Brisbane 12
Christchurch 12
Hamilton 12
Prineville 12
Tokyo 12
Baghdad 11
Chennai 11
Chicago 11
Perth 11
Porto Alegre 11
Boston 10
Dormagen 10
Fuzhou 10
Kunming 10
London 10
Napoli 10
Phoenix 10
Pompei 10
Totale 21.117
Salva come PNG Salva come JPEG
Nome #
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 165
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 161
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 158
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 151
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 144
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 142
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 137
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 133
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 129
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 128
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 125
The natural history of multiple system atrophy: A prospective European cohort study 121
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 120
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 118
Normative data for the Montreal Cognitive Assessment in an Italian population sample 117
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 116
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 115
Increased bilirubin levels in de novo Parkinson's disease 114
Affective theory of mind in patients with Parkinson's disease: comment 113
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: A randomised, placebo-controlled trial 113
The "gender factor" in wearing-off among patients with parkinson's disease: A post hoc analysis of DEEP study 111
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 111
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 109
Long-term safety of rivastigmine in parkinson disease dementia: An open-label, randomized study 109
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. 107
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 107
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 105
Sindromi parkinsoniane 105
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 103
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 103
The alpha-synuclein gene in multiple system atrophy 101
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 101
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 100
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 100
The accuracy of the arginine growth hormone test in parkinsonism. 99
D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine. 99
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 99
Gender and non motor fluctuations in Parkinson's disease: A prospective study 98
Diagnosis and management of Parkinson's disease dementia. Oct;62(10):1581-7. Review.PMID: 18822028 97
Clinical variables associated with treatment changes in Parkinson’s disease: results from the longitudinal phase of the REASON study 97
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 97
Malabsorption is uncommon in restless legs syndrome. 96
Aiming for study comparability in Parkinson's disease: Proposal for a modular set of biomarker assessments to be used in longitudinal studies 95
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 95
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 95
Apathy and related executive syndromes in dementia associated with Parkinson's disease and in Alzheimer's disease 94
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 94
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 94
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 93
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients. Aug 15;23(11):1532-40.PMID: 18581467 93
Prophylaxis of migraine attacks with a calcium-channel blocker: flunarizine versus methysergide 93
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 93
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 93
Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease. 92
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 92
Pisa syndrome in Parkinson disease: An observational multicenter Italian study 92
Dopamine mediated responses in 6-OH-DA lesioned rats involve changes of the signal transduction. 91
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 91
Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression? 91
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 91
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 90
On the relationship between side of onset and cognition in Parkinson disease 90
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family 90
Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study 90
The relevance of gender in Parkinson's disease: a review 89
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 89
Nitric oxide-haemoglobin interaction: a new biochemical hypothesis for signal changes in fMRI. 89
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 89
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 89
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 89
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 89
Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's disease 88
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 88
Apathy in Parkinson's disease: Diagnosis, neuropsychological correlates, pathophysiology and treatment 88
Quitting smoking: An early non-motor feature of Parkinson's disease? 87
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. 87
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. 87
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Sep;132(Pt 9):2350-5. PMID: 19584099 87
Early MRI findings in acquired hepatocerebral degeneration. 87
Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors. 87
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 87
Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards 87
Bisphenol A glucuronidation in patients with Parkinson's disease 87
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 87
Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors. 86
D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models andparkinsonian patients. 86
Abnormal eating behaviors in progressive supranuclear palsy. 86
Plasma prolactin response to sodium valproate in epileptic patients 86
Pramipexole in patients with early Parkinson's disease (PROUD): A randomised delayed-start trial 86
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease-Report of the JPND Working Group BioLoC-PD 86
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 85
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale 85
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 85
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 85
Efficacy and safety of extended- versus immediate-release pramipexole in Japanese patients with advanced and (L)-dopa-undertreated Parkinson disease: a double-blind, randomized trial. 84
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 84
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 84
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 84
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 84
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family 84
Totale 10.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.645 24 248 270 10 363 136 344 19 305 22 341 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/2026521 521 0 0 0 0 0 0 0 0 0 0 0
Totale 31.556